This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Ernst-Jurgen Schneider: Innovator in Nerve Damage Treatment
Introduction
Ernst-Jurgen Schneider is a notable inventor based in Bad Camberg, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of nerve damage. His innovative work has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Schneider holds a patent for the "Use of xanthine derivatives for the treatment of nerve damage following an interruption in blood circulation." This invention involves the use of xanthine derivatives that can be formulated into medicaments aimed at preventing and treating nerve damage caused by blood circulation interruptions. The patent details specific chemical structures and processes for preparing these novel xanthine derivatives, which are crucial for medical applications.
Career Highlights
Throughout his career, Ernst-Jurgen Schneider has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has focused on developing innovative solutions that enhance medical treatments and improve patient outcomes. Schneider's dedication to research and development has positioned him as a key figure in his field.
Collaborations
Schneider has collaborated with notable colleagues, including Werner Thorwart and Harald Furrer. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to advancements in medical treatments.
Conclusion
Ernst-Jurgen Schneider's contributions to the field of medicine through his patent on xanthine derivatives highlight his commitment to improving healthcare. His work continues to influence the development of effective treatments for nerve damage, showcasing the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
